Cargando…
SAT-475 PRL Secreting Macroadenoma and Development CSF Leak Secondary to Cabergoline Use
Background: Macroprolactinomas are normally managed with dopamine agonists, resulting in tumor shrinkage and normalization of prolactin. Occasionally they can invade the skull base, erode the sellar floor, and extend into the sphenoid sinuses. Rarely, dopamine agonist therapy can result in spontaneo...
Autores principales: | Ulrich, Jenna, Omay, Sacit, Manes, Peter, Majumdar, Sachin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552443/ http://dx.doi.org/10.1210/js.2019-SAT-475 |
Ejemplares similares
-
SAT-272 Pituitary Macroadenoma Co-Secreting TSH and PRL Responsive to Cabergoline
por: Tirumalasetty, Saritha, et al.
Publicado: (2020) -
FRI321 Aggressive Prolactinoma Empirically Treated With Cabergoline Leading To Rapid CSF Leak
por: Yau, Alice, et al.
Publicado: (2023) -
SAT-270 Priapism Secondary to Cabergoline
por: Amir, Maryam, et al.
Publicado: (2020) -
SAT-467 Gigantism Caused by Growth Hormone-Secreting Pituitary Macroadenoma: A Case Report
por: Tham, Ye Ni, et al.
Publicado: (2019) -
SAT-487 Unusual Case of Plurihormonal Pituitary Macroadenoma
por: Allehaibi, Ebtesam, et al.
Publicado: (2019)